July 16, 2020
Jerusalem-based Teva Pharmaceuticals announced this week the U.S. launch of its ProAir Digihaler.
The sensor-laden albuterol dispenser requires a prescription, and is indicated for those aged four years or older with reversible obstructive airway diseases such as asthma and COPD, as well as for the prevention of exercise-induced bronchospasm (EIB) among this same group.
The device connects to a...
December 31, 2018
Jerusalem-based Teva Pharmaceuticals’ sensor-packed, app-connected digital inhaler has recently received marketing approval from the US FDA, according to a release from the company. The device will first become available next year through a “small number” of healthcare system pilot partnerships, with a full national launch currently planned for 2020.
Teva’s ProAir Digihaler is indicated for the...
September 20, 2017
BioSensics, a Cambridge, Massachusetts-based developer of wearable health sensors, has received more than $2.5 million in NIH grant funding for its Huntington’s disease (HD) monitoring device.
The device, called HDWear, provides real-time quantitative motor symptom scores that can assist with managing the hereditary neurological disease. These measures usually require in-clinic assessments such...
October 26, 2016
Global pharmaceutical company Teva has joined forces with IBM in a three-year research collaboration that integrates with the Watson Health Cloud. The project builds on an existing alliance between the two companies and will focus on two key areas in healthcare: developing a systematic approach to discovering new uses for existing drugs and improving chronic disease management.
The joint work in...
September 27, 2015
Teva Pharmaceuticals will acquire Cambridge, Massachusetts-based Gecko Health Innovations (previously known as GeckoCap), a smart inhaler company. The terms of the deal were not disclosed.
Gecko's main product is CareTRx a platform for chronic respiratory disease management that combines a sensor device that connects to most inhalers, a data analytics platform, an accessible user interface, and...
June 4, 2015
While Teladoc has been pulling in a lot of press lately with its IPO news, competitor American Well has been busy too, securing an eight-figure investment from Israeli pharmaceutical giant Teva, according to a recent report in Israeli publication Globes.
According to Globes, the investment of "tens of millions of dollars" is part of a new push into digital health by Teva, which has also included...